Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 64

1.

Pharmacokinetic drug interaction profiles of proton pump inhibitors.

Blume H, Donath F, Warnke A, Schug BS.

Drug Saf. 2006;29(9):769-84. Review.

PMID:
16944963
2.

Pharmacokinetic drug interaction profiles of proton pump inhibitors: an update.

Wedemeyer RS, Blume H.

Drug Saf. 2014 Apr;37(4):201-11. doi: 10.1007/s40264-014-0144-0. Review.

3.

Pharmacokinetics, metabolism and interactions of acid pump inhibitors. Focus on omeprazole, lansoprazole and pantoprazole.

Andersson T.

Clin Pharmacokinet. 1996 Jul;31(1):9-28. Review. Erratum in: Clin Pharmacokinet 1996 Oct;31(4):274.

PMID:
8827397
4.

[New-generation proton pump inhibitors: progress in the treatment of peptic acid diseases?].

de Korwin JD, Ducrotté P, Vallot T.

Presse Med. 2004 Jun 19;33(11):746-54. Review. French.

PMID:
15257232
5.

Review article: drug interactions with agents used to treat acid-related diseases.

Humphries TJ, Merritt GJ.

Aliment Pharmacol Ther. 1999 Aug;13 Suppl 3:18-26. Review.

6.
7.

Pharmacokinetics of proton pump inhibitors in children.

Litalien C, Théorêt Y, Faure C.

Clin Pharmacokinet. 2005;44(5):441-66. Review.

PMID:
15871633
8.
9.

[Clinical pharmacological aspects of the proton pump inhibitor therapy: importance of pharmacogenetic differences in the clinical practice].

Mullner K, Molnar B, Tulassay Z.

Orv Hetil. 2007 Mar 25;148(12):543-51. Review. Hungarian.

PMID:
17444020
10.

New-generation proton pump inhibitors: overcoming the limitations of early-generation agents.

Robinson M.

Eur J Gastroenterol Hepatol. 2001 May;13 Suppl 1:S43-7. Review.

PMID:
11430508
11.
12.

Stereoselective disposition of proton pump inhibitors.

Andersson T, Weidolf L.

Clin Drug Investig. 2008;28(5):263-79. Review.

PMID:
18407713
13.

Evaluation of omeprazole, lansoprazole, pantoprazole, and rabeprazole in the treatment of acid-related diseases.

Welage LS, Berardi RR.

J Am Pharm Assoc (Wash). 2000 Jan-Feb;40(1):52-62; quiz 121-3. Review.

PMID:
10665250
14.

Review article: cytochrome P450 and the metabolism of proton pump inhibitors--emphasis on rabeprazole.

Ishizaki T, Horai Y.

Aliment Pharmacol Ther. 1999 Aug;13 Suppl 3:27-36. Review.

15.

Drug interaction studies with esomeprazole, the (S)-isomer of omeprazole.

Andersson T, Hassan-Alin M, Hasselgren G, Röhss K.

Clin Pharmacokinet. 2001;40(7):523-37. Review.

PMID:
11510629
16.

[Protonic pump inhibitors in kidney transplant patients: efficacy and safety].

Cianciolo G, Feliciangeli G, Comai G, Stefoni S.

Minerva Urol Nefrol. 2007 Jun;59(2):207-15. Review. Italian.

PMID:
17571057
17.

Esomeprazole: a review of its use in the management of acid-related disorders.

Scott LJ, Dunn CJ, Mallarkey G, Sharpe M.

Drugs. 2002;62(10):1503-38. Review.

PMID:
12093317
18.

[Interaction between clopidogrel and proton pump inhibitors].

Harmsze AM, de Boer A, Boot H, Deneer VH, Heringa M, Mol PG, Schalekamp T, Verduijn MM, Verheugt FW, le Comte M.

Ned Tijdschr Geneeskd. 2011;155(28):A2442. Review. Dutch.

PMID:
21771377
19.

Proton pump inhibitors and their drug interactions: an evidence-based approach.

Gerson LB, Triadafilopoulos G.

Eur J Gastroenterol Hepatol. 2001 May;13(5):611-6. Review.

PMID:
11396546
20.

Supplemental Content

Support Center